Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03786718 · ClinicalTrials.gov registry record · NA

Usability of Diabetes Dashboard Embedded Within a Patient Web Portal

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
69
Enrollment target

NCT03786718: Completed NA study, sponsored by Vanderbilt University Medical Center.

NCT03786718 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03786718, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a prospective, longitudinal study to evaluate the usability of a patient-facing diabetes dashboard delivered via an established patient web portal.

Primary Outcome

The System Usability Scale (SUS) will be administered to all study participants at one month follow-up (T1). The SUS is a validated measure of usability. The ten items are scored on a five-point Likert scale. The item scores are summed and then converted to a score ranging from 0 (worst) to 100 (best). A score of above 68 indicative of "above average" usability.

Interventions

  • OTHER Patient-facing Diabetes Dashboard

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2018-12-27
Est. Completion 2019-05-13
Phase NA

What the finished NCT03786718 record still lists

NCT03786718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient-facing Diabetes Dashboard is the first listed.

NCT03786718 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03786718 about?

NCT03786718 is a clinical study titled "Usability of Diabetes Dashboard Embedded Within a Patient Web Portal". The purpose of this study is to conduct a prospective, longitudinal study to evaluate the usability of a patient-facing diabetes dashboard delivered via an established patient web portal.

What is the current status of trial NCT03786718?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2018-12-27. Estimated completion is 2019-05-13.

What interventions are being tested in trial NCT03786718?

The interventions under investigation include: Patient-facing Diabetes Dashboard (OTHER).

Who is sponsoring clinical trial NCT03786718?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03786718's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03786718, the US trial registry maintained by the National Library of Medicine. NCT03786718 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.